180 likes | 656 Views
Rett Syndrome. It’s Not Just for Girl’s Anymore . Craig Dobson, MD CPT, MC, USA NCC Pediatrics Residency Program. Clinical Characteristics. Developmental regression Progressive microcephaly Stereotyped hand movements Seizures. Characteristics. Disordered breathing Ataxia Scoliosis
E N D
Rett Syndrome It’s Not Just for Girl’s Anymore. Craig Dobson, MD CPT, MC, USA NCC Pediatrics Residency Program
Clinical Characteristics • Developmental regression • Progressive microcephaly • Stereotyped hand movements • Seizures
Characteristics • Disordered breathing • Ataxia • Scoliosis • Time course progression
Stage I • Age 6-18 months • Minor delays • Postural reflexes delayed • ‘Bottom shuffling’ common • Often normal
Stage II • Age 1-2yr • Regression • Personality phenotype • Difficult to control • Screaming fits • Occasional self injurious behavior
Stage II, cont. • Hand movements • Wringing • Flapping • Automatisms • Disordered breathing • Hyperventilation • Apnea • Air swallowing
Stage III • Usually begins age 3-4 • Regaining and improving communication • Improved behavior • Stable to slowly declining motor function • Seizures • Generalized or partial • Late stage II to early III
Stage III, cont. • Sleep disturbance • Night laughter Early stage III (83%) • Night screaming fits later stage III • Bruxism • Scoliosis
Stage IV • Adult life • Progressive lower motor deterioration • Progressive severe neurogenic scoliosis • Preserved communication • Improved control of seizures • Improved behavioral phenotype
Epidemiology • 1:10,000-15,000 females • Rare but present in males • Unknown atypical prevalence
Genetics • MECP2 Gene • X-Chromosome inactivation • Mosaicism
Prognosis/Life expectancy • Classic Rett Syndrome • 7% survive beyond age 40 • Unexplained sudden death common • Atypical Rett Syndrome • Mosaics
Clinical Implications • Genetic testing • Females (incl atypical presentations) • Males (mosaics) • Genetic couselling • Recognition of carrier state • Prenatal testing
Clinical Implications, cont. • New medication options • Buspirone for breathing abnormalities • Melatonin for sleep disturbances • L-carnitine in preserving neurologic function. • Targeting learning modalities • Music • Non-speech communication
Future • Expanded genetic testing • Recognition of more atypical presentations • Mouse model testing of therapeutics • Further understanding of gene’s regulatory role